Share Name Share Symbol Market Type Share ISIN Share Description
Pipex Communications LSE:PXC London Ordinary Share GB0005846018 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 7.25p 0.00p 0.00p - - - 0.00 05:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Unknown 294.4 -17.7 -0.8 - 0.00

Pipex (PXC) Latest News

Real-Time news about Pipex Com. (London Stock Exchange): 0 recent articles
More Pipex News
Pipex Takeover Rumours

Pipex (PXC) Share Charts

1 Year Pipex Chart

1 Year Pipex Chart

1 Month Pipex Chart

1 Month Pipex Chart

Intraday Pipex Chart

Intraday Pipex Chart

Pipex (PXC) Discussions and Chat

Pipex Forums and Chat

Date Time Title Posts
07/1/201111:20Pipex - Wimax - the next telecoms revolution28,144.00
16/8/200717:00Only worth 3.75p on fundamentals5.00
08/8/200710:09OO7 FOR YOUR EYES ONLY6.00
27/7/200717:18Is Pipex the next gutter stock !36.00
26/7/200718:46THE MAN WITH GOLDEN FINGER "H" 007.KIDDA YAAR3.00

Add a New Thread

Pipex (PXC) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Pipex trades in real-time

Pipex (PXC) Top Chat Posts

DateSubject
03/1/2008
08:20
veryoldbob: If that 130M figure is correct, that makes the current share price about right. PXC got 187M after adjustments from Tiscali, which makes say £317, minus about 100M of debt leaving £217M and with 2.4bn shares in issue, that works out at 9p a share. Extra value may come from a stake in the demerged Freedom4 to bump that up a bit. That old City phrase "buy the rumour, sell the fact" comes to mind. PXC has always risen on rumours and then fallen when the real facts come out.
21/12/2007
08:52
bobdown2: until dubens clears the uncertainties that he has created then pxc looks as if it will tread water..it is a shame because with the broadband money he had a chance to make some of his astute aquisitions. the share price now looks as if has bottomed and is now waiting for the news to see if it is marked up or down depending if dubens is picking up pxcs assets on the cheap
28/11/2007
19:14
spights: Hi Markie the loan stock can be used for shorting. It helps me with the direction of the share price.So if the loan stock falls to 10% the share price will rise.
13/11/2007
18:49
spights: Hi PhilAJ.I use the loan stock to see if there is a rise or fall in the figures. Below its increased. When the loan stock falls the share price should rise.Its also a guide on shorting.This is my reading of it. 08/11/2007 PXC GB0005846018 PIPEX COMM ORD 1P OTH 304.62 2337.28 13.03 2444.32 12.46 95.62 07/11/2007 PXC GB0005846018 PIPEX COMM ORD 1P OTH 304.62 2337.24 13.03 2444.32 12.46 95.62 06/11/2007 PXC GB0005846018 PIPEX COMM ORD 1P OTH 301.18 2337.32 12.89 2444.32 12.32 95.62
10/11/2007
19:31
veryoldbob: PD's share options from the Annual Report 2006: 8,400,000 6.25p 24 October 2003 to 23 October 2013 1,600,000 6.25p 24 October 2003 to 23 October 2013 3,333,333 7.50p 11 April 2005 to 10 April 2015 4,912,280 14.25p 7 April 2006 to 6 April 2016 The first two are exercisable. The third kicks in when share price is 12p, the fourth at 18p. So at today's share price PD can nab 10M shares at 6.25p and foregoes the 8.2M at the higher prices. He might be tempted to lose any potential profit from the third and fourth options if OPD gets the Business and Hosting Divisions for a song. PXC also made this statement: "On 17 January 2007 options were granted to the directors, Peter Dubens, 6,792,452, Mike Read, 6,037,735 and Stewart Porter 4,452,830 at 13.25p. 60% of the options are exercisable between 17 January 2008 and 16 January 2017 and 40% are exercisable between 17 January 2009 and 16 January 2017." Hmm - think those exercise dates are a tad optimistic. PD's likely to be long gone by 2009!
10/11/2007
15:02
bobdown2: vob......articles like that and the silence from pxc on their progress if they are making any doesnt help a falling share price. it looks like there are concerns about the costs of rolling out wimax or even if it will be rolled out at all. given that manchester was being rolled out in the 4th quarter a progress report would be nice even if it dented an already battered share price. at least then it would give investors enough information to get out. as it is pxcs graph looks simular to some other aim stocks that have been hit. but as long as dubens does not do anything underhand then at some stage given time then we could see a recovery...ps just about to watch the bond film in my undies and tin hat and i will need them again on monday after fridays falls on the dow!
23/10/2007
19:58
bamboo2: Date Posted: 2007-08-03 09:01 Oakley Capital Inv. - First Day of Dealing on AIM RNS Number:4548B Oakley Capital Investments Limited03 August 2007 OAKLEY CAPITAL INVESTMENTS LIMITED First day of dealing on AIM The Board of Oakley Capital Investments Limited (the "Company"), today announcesthe placing of 100,000,000 ordinary shares at #1.00 per ordinary share withwarrants attached on a 1 for 2 basis, raising gross proceeds of #100 million. All of the ordinary shares and warrants in the Company have today been admittedto trading on AIM. Collins Stewart Europe Limited acted as broker to theplacing. The Company has been set up to invest primarily in Oakley Capital Private Equity L.P. (the "Fund"), a new private equity fund being established by a team ofexperienced investment professionals led by Peter Dubens, executive chairman of Pipex Communications plc and former chairman of 365 Media Group plc. The Fund'sinvestment advisory team has an average of 10 years' successful investmentexperience, in M&A, private equity and operational management. The Fund will invest primarily in mid-market buy-outs in the UK and Europe. Itwill seek to acquire controlling positions in companies with scope forperformance improvement, and in industries with strong underlying growth driversand the potential for consolidation. The Fund will utilise the investmentadvisory team's proven ability to self-source transactions and actively manageportfolio companies to improve operational performance. The Fund will targetequity transactions in the range of #20 to #100 million and will seek to delivergross IRR on its investments in excess of 25% per annum and a blended grossmultiple of three times. The Fund is seeking commitments of up to #375 million from limited partners. The directors and employees of the investment advisory team have committed toinvest #12 million of their own capital in the Fund. The first closing of the Fund is expected to be shortly after admission. Following the placing, the Company is aware of the following persons who have aninterest either directly or indirectly in 3% or more in the capital of the Company: Invesco Perpetual 25.0% Kingdon Capital Offshore 10.0% Moore Capital 10.0% GAM 9.0% Fidelity 7.5% Schroders 6.0% Gartmore 5.0% Insight 5.0% Powe Capital 5.0% UBS 4.0% --oo-- For further information please contact: Oakley Capital Limited 020 7766 6900 Peter Dubens (Chairman) David Boyd (Investor Relations) Collins Stewart 020 7523 8325 Hugh Field Jonny Sloan Financial Dynamics 020 7831 3113 Juliet Clarke Edward Bridges Hannah Sloane Collins Stewart Europe Limited, which is authorised and regulated by the Financial Services Authority in the conduct of investment business, is actingexclusively for Oakley Capital Investments Limited and for no-one else inconnection with the placing and will not be responsible to anyone other than Oakley Capital Investments Limited for providing the protections afforded tocustomers of Collins Stewart Europe Limited or for providing advice in relationto the issue.3 August 2007 Notes to Editors Background to previous experience of investment adviser's team Oakley Capital (Bermuda) Limited (the "Manager"), has been appointed as managerto the Company and the Fund. The Manager has appointed Oakley Capital Limited(the Investment Adviser") as investment adviser to the Manager. The Investment Adviser will be primarily responsible for advising the Manager on theinvestments of the assets of the Fund and the Company The Investment Adviser's team, who were instrumental in generating the returnsproduced by 365 Media Group plc ("365") and Pipex Communications plc ("Pipex")whilst those companies were under the Chairmanship of Peter Dubens, have managedcompanies with a combined enterprise value averaging over #210 million over the5 years to December 2006.365 was sold to BSkyB in December 2006 generating an IRR of 23% from itsadmission to trading on AIM on 6 August 2001 to the end of December 2006. Theshare price of 365 increased by 2.7 times over the same period. Based on the average share price of 13.78 pence over the 3 months to 30 June2007, Pipex has delivered a 32% IRR to investors since Peter Dubens became adirector of Pipex on 23 October 2002, and the share price of Pipex has increasedby 6.1 times over the same period. Both businesses were grown by undertaking an active M&A, and capital raisingprogramme in conjunction with operational restructuring and strategicrepositioning. The Investment Adviser's team has worked together for over 5 years and hascompleted 26 acquisitions and disposal transactions on behalf of 365 and Pipex. The manager believes this track record demonstrates the Investment Adviser'steam's ability to source, execute, integrate, run, grow and then sellbusinesses. This information is provided by RNS The company news service from the London Stock Exchange
15/4/2007
18:38
drunker50: The stock market made a very big mistake by allowing the mos article have such a big impact on the pxc share price. I bet all the newspapers are licking their lips at the prospect of all this power that is now in their hands, the stock market is making it's bed and will have to lay in it because the papers will make an absolute fortune from this new found power which as been handed to them by a very weak stock market. It'll be ok boys go short on so and so cos we gonna put out an article on the weekend, the easiest 30% you'll ever make. corrupt and pathetic and blatantly obvious.
12/3/2007
11:49
patboy: were: Paul Murphy (PM) Neil Hume (NH) PM: Welcome to Markets Live, the live daily market commentary from the Alphaville team. PM: I'm joined by Neil Hume from the FT's London equities team. PM: He's just told me to hang on a minute PM: Seems to be looking for something PM: Muzak NH: morning PM: Muzak NH: I'm just routing through the drawer with all these emoticons in it PM: What you doing in there? NH: Looking for ...not the dead cat, not the bandit, not the bull, not the lightbuld NH: I'm sure we had one of a Muppet PM: What? To illustrate the muppets we looked like this morning? NH: That's right PM: Ok – for those readers who do not yet received our morning email – the 6am Cut – we had certain technical problems. NH: Yes, you hadn't taken account of the clocks changing in the US. And so umpteen thousand got up to read the financial news and were led to believe nothing was going on. PM: Hmm. Basically we have software that picks up our early Alphaville posts on our home page just before 6am and sends them out as an email. PM: But that's 6 am GMT. It seems our software – Word Press – which is American, thinks in EST terms. Cos the clocks had changed in the US, it picked up the Alphaville content just before 5am rather than 6am – and so there were only a handful of stories there. NH: Great – you've got us software that doesn't understand that GMT is the international benchmark for time. Muppet. PM: Hmm. We had better get it fixed. PM: In the meantime, maybe you can help bring readers back up to speed? NH: Happy to do that NH: It is now 11.05 am, precisely, Greenwich Mean time. And the key things you should know are this: NH: Stefano Pessina, deputy chairman of Alliance Boots, has linked up with KKR to try and take the group private. It's come as a complete shock since it is less than a year since Pessina form the group with the Boots merger. NH: ICI stock has jumped after news that Akzo Nobel of Holand has sold its drugs business, Organon, to Schering-Plough. PM: But we'll come back to both those features. PM: Other stuff we should know? NH: Well, we've seen an early rally on the FTSE 100 fizzle out. We were about 30 points higher at one stage this morning. Right now it is up 8.8 points at 6254 - having just threatened to fall into negative territory. NH: That said , the dollar perked up a bit overnight, with some people calming down on the overall state of the world economy. NH: That in turn helped Asian stock markets. Hang Seng was up just over 300 points at 19442, Nikkei was up 128 at 17292, etc PM: Crude down a bit, I see. Gold up a fraction. PM: OK, tell me about Alliance Boots. What do people make of this news? NH: well, let's look at the share price reaction first NH: stock up 70p at £10 PM: That is one serious move NH: yes. it come as the board of Boots meets to consider whether the high street chemist should open its books to executive deputy chairman, Stefano Pessina PM: We should just say here, that Mr Pessina and private equity firm Kohlberg Kravis Roberts announced after the market closed on Friday that they had approached Boots with an indicative offer of £10-a-share NH: They did and the fact that the shares are already trading in line with the terms of the offer is interesting PM: So risk aversion has gone straight back out of fashion NH: it has. this morning's move in the Boots share price implies that the market thinks (A) there could be another bidder out there or (B) Mr Pessina will be forced to increase his offer PM: So what is the view on the offer? NH: The prevailing view seems to be that it is generous offer but Mr Pessina should not be trusted because he can probably see value that everyone else cannot PM: Ultimate insider .... top management and patial owner NH: indeed. NH: i have put together a round-up of analyst comment to give you a flavour of how the bid news has gone down with the City PM: Excellent - very timely NH: I'll start with Deutsche Bank NH: Of all the potential LBO candidates in the retail sector, investors will be surprised by the approach for Alliance Boots. The 1000p offer from Executive Deputy Chairman Stefano Pessina looks generous but he can clearly see value which the market does not currently appreciate. Our analysis suggests 'hidden value' of at least 223p per share. Investors may be able to sell above 1000p but probably not above 1100p. NH: This is from Dresdner Kleinwort NH: It is bizarre that Pessina is seeking a buy-out so soon after the merger, when a cash bid for Boots two years ago might have made more economic sense. We suspect Pessina (65) is keen to move faster than institutional shareholders would feel comfortable with, in order to take advantage of consolidating international healthcare markets. NH: While the move is likely to be politically unpopular, it is difficult to see any buy-out being blocked on competition grounds as this offer involves no more than a change in ownership. From a valuation perspective, the offer looks generous and must have a realistic chance of success. NH: This is from Sanford C Bernstein, which was one of just two brokers to have a buy rating on Boots before the bid approach NH: In order to assist Alliance Boots investors in thinking through what a "fair price" could be, we have laid out our longer-term "growth" value creation scenario, which we think more fairly reflects how Mr. Pessina would view the value of the company. NH: In order to assist Alliance Boots investors in thinking through what a "fair price" could be, we have laid out our longer-term "growth" value creation scenario, which we think more fairly reflects how Mr. Pessina would view the value of the company. NH: Given KKR's likely objectives, combined with Pessina's role in the proposed deal, we now think it is appropriate to include our longer-term "growth" scenario in our valuation work (and published model). In this scenario, the company would nearly double its EV to c£20bn in 5 years (almost doubling its EBITDA), implying a maximum take-out price today of £13 while maintaining a 20% IRR for the acquirers. PM: great - people say oh he's an insider, trying to buy on the cheap - but then there's only two "buy" notes out there when he makes his move. PM: Belated PM: Got any more analysis? NH: and this is from Nick Bubb at Pali International PM: Your Pali pal NH: The fact is that £10 is a generous price: this equates to a PE of nearly 23 for y/e March 2007 and an EV/EBITDA of 12.2. We think KKR would struggle to get even a 10% IRR at that price, unless EBIT margins can be driven over 7% (which seems implausible). NH: But the perception will be that £10 isn't enough, given the conflicts of interest and the pressure for a proper auction. There may be trade rival bidders, though Celesio (the big German drug wholesaler) is very unlikely to get EU takeover approval. But there may be other private equity interest and there is scope for a sweetener from KKR. So we would resist the strong temptation to take KKR's money and run. NH: We therefore expect the AB share price (930p at the close on Friday) to move over £10 today, pending more news from the Board meeting set up to decide whether to open the books to KKR PM: As you said, the view seems to be that £10 is fair but there is hidden value in Boots PM: Can we go back to the Deutsche Bank note, how do they come to this figures of 223p-of hidden value? NH: hang on, I will get it. NH: OK here's the maths behind that figure NH: Recovery of Boots the Chemist (BTC) margins which fell from 15.4% in 2001/2 to 7.4% estimated in 2006/7. Estimated 100p of value. NH: Deal synergies of over £200m. Estimated 70p of value. Pessina always made it clear that £100m was very conservative, the question is just how conservative. NH: The opportunity to take the Boots brand (products, not stores) overseas is significant. Estimated 53p of value. We look into this in more detail below. NH: There is upside in the wholesale business from deregulation of key markets (Italy, Spain etc) and potentially accretive acquisitions having been identified. Unquantified value. NH: Deutsche also makes the point that these figures do not take in account any incremental benefit from rationalizing Boots' Nottingham headquarters PM: How much value would that add? NH: dunno but the headquarters is bigger than Monaco. PM: Yeah, right ! But it's not on the Cote d'Azur NH: probably not but that's a lot of land NH: even if it is in the murder capital of Britain PM: PM: needs regenerating, clearly NH: here's some comment from Man Securities on the HQ in Britain's gun crime capital NH: Asset backing for Alliance Boots is low compared to its food retail peers. We estimate that Alliance Boots freehold exposure is 15-20% of group property exposure. We estimate freehold and long-leasehold assets could yield in excess of £1bn. NH: However, the Boots headquarters in Nottingham has never been revalued. We estimate this 300 acre site is worth in excess of £350m. We feel this transaction is predicated on the cash flow generated by the group. We estimate Alliance Boots generates 8-9% cash flow yield. This compares with Tesco at 3% PM: Libelling Nottingham, you know NH: it's not libel but a well know tabloid fact PM: town NH: have we got a body armour icon? PM: enough! - actually that research is v interesting. People have had to put their thinking caps on this morning PM: OK. We should now turn to Sainsbury PM: has the price been affected by the move on Boots? NH: It has. Biggest faller in the FTSE 100 at the moment, down 13p at 531p PM: Hmm NH: Real worries that the bidding consortium might fall apart now that KKR – one of its members – is working on another mega bid in the retail sector. NH: actually there were a couple of stories around in the weekend press, suggesting that there are difference of opinion within the consortium about the political ramifications of doing a deal PM: I reckon Robert Tchenguiz – who increased his holding in the supermarkets group to 3% last week – must be feeling a bit uneasy NH: Yep, unless he is betting on another bidder appearing PM: Like who?? NH: the Qatar state investment authority PM: Ok - maybe. But suspect if they do anything it will be in the form of a minority stake NH: yeah probably. PM: Right - tell me about that other big feature this morning __ ICI NH: shares flying, up 31p to 496p PM: Explain .... NH: Akzo Nobel has sold its drugs business Organon BioSciences to Schering Plough for euro 11bn PM: That's much more than the market was going for earlier NH: It is. Akzo was going to demerger 30% of this business, which analyst valued at euro8bn-10bn NH: they are now selling all of it for euro11bn to a trade buyer, which is obviously much quicker and cleaner PM: Much cleaner and quicker PM: If they were floating it they would still ahve a substantial stake - so only the paper proceeds - not the whole lot to spend on acquisitions elsewhere NH: that's true. as it is they have a euro11bn warchest. PM: So Akzo to bid for ICI !!! NH: looks that way PM: NH: did you see the comment Akzo made after announcing the sales of Organon PM: No, not in detail NH: here they are NH: Akzo Nobel aims to continue to grow in the most attractive areas of its coatings and chemicals portfolios through investments and acquisitions, based on a disciplined and value- driven approach to earnings and returns over cost of capital. Consistent with the company's stated objectives, the proceeds of this sale provide room to deliver on its growth ambitions and to reduce Akzo Nobel's pension and other liabilities. PM: Hmm - looks like they are trying to talk up the price of the target! PM: In fact, it is so blatant, makes me wonder whether they have something else in mind. PM: Anyway,. got any analysts comment? NH: this from Collins Stewart, the broker that first floated the idea of a Akzo bid for ICI NH: Bid from Akzo more likely – upgrade PT to 550p NH: Akzo's cash disposal of pharma makes a bid for ICI more likely - we now assume a 50% chance, up from 25%. Akzo could pay up to 600p for ICI and meet EVA hurdles in year 2. NH: Akzo intends to make acquisitions in coatings (and chemicals). The immediate use of cash is 10% share-buyback (c.EUR1.3bn). We stick with our logic that a bid for ICI would make perfect strategic sense, is doable from a regulatory perspective, and now doable financially (a big of up to 600p would equate to an ICI EV of c.EUR11bn). Synergies, particularly in raw material purchasing, would be significant. PM: Right - interesting. And probably fair odds PM: So waht else is moving this morning? NH: Smith & Nephew up 19.5p to 635p following news that it is to buy a privately owned Swiss company called Plus Orthopedics for almost $900m cash NH: Rexam up 9.5p to 529.5p after announcing plans to sell its glass business to Ireland's Ardagh glass for euro600m PM: So quite a bit of corporate action NH: for a Monday, yes. PM: Ok, what else have we got a bit lower down the corporate scale? NH: Pipex PM: That's the broadband internet company run by that 'colourful' entrepreneur Peter Dubens NH: It is and late on Friday its shares spiked 15 odd percent in heavy volume PM: Why? NH: bid rumours and this morningt the company admitted appointing advisers to find a buyer PM: Yes, and then story in the Sun Express NH: here's the statement NH: Pipex Communications plc ("Pipex" or the "Company") notes the recent press speculation concerning the Company. Pipex confirms that it has appointed UBS to investigate a number of strategic options, which could include a sale of the Company. This process is at a very early stage and there can be no certainty that a transaction will result. A further announcement will be made in due course. PM: Interesting. The retail punters love this stock don't they? PM: So who might buy Pipex? NH: Any of the big broadband providers or a telecoms company NH: in fact just got some feedback from a PM: That's a felt collared source - a PR - not always helpful, but they are somethimes NH: Apparently Pipex have a"a few" takeover approaches. the likely contenders include Tiscali, Carphone Warehouse and Orange. PM: Hmm And what sort of price are we looking at NH: i reckon anything about to the early 20p's NH: got this note from Ambrian Partners this morning NH: We are upgrading Pipex from Hold to BUY on further consideration of the strategic value of its assets. Our new price target is 18p, equivalent to an enterprise value of £470m, or around £800 per broadband customer. NH: i reckon that target price could prove conservative PM: Why? NH: have you seen what Swisscom are paying for Fastweb, an Italian broadband internet group? PM: No PM: Is it much higher? NH: it is not a totally fair comparison but around £3,000 per subscriber PM: That's aggressive. NH: It is. But it makes the £800 figure above look conservative, especially as Pipex has a Wimax liencese and hosting activities, NH: hang on just had some more comment from another broker PM: Who? NH: Byrant Garnier NH: We believe the main interest comes from BT group, who we believe are very keen on the nationwide wireless licence that Pipex is using to develop a Wimax service. However, with also a strong hosting operation and 4.4% of the UK broadband market there are also good reasons for Orange, BSkyB and Carphone Warehouse to acquire Pipex. We could also include O2 and T-mobile as potential bidders based on general convergence trends as mobile companies combine broadband with mobile services. PM: What are the shares doing?? NH: unchanged at 13.75p PM: One to what PM: Now, I was poking around AIM earlier and came across Entelos Inc PM: What do you know about this? NH: American life sciences company – from Foster City, California. NH: All the way to AIM ... PM: Clearly, they don't have investors over there who are ready to focus on science venture type opportunities. NH: Well, this is a company that has boasted of producing "virtual patients" – predictive computer models of human disease. NH: Raised just over £10m last April at 83p a share. PM: Sounds very noble– great idea, abolish the need to use human guinea pigs in drug trials, etc NH: Great idea – do you want the reality? PM: Go on NH: Well, it announced a string of deals with the likes of Unilever, J&J, Pfizer NH: But today we have news that two customers – important customers I guess have ... and I quote NH: Reprioritized their internal clinical programmes NH: So there will be a decrease in expected revenue for 2007. NH: Not cancelled,mind! Just reprioritized – so a delay to revenues. PM: Hmm. So what's has the market made of this reprioritzation? NH: Shares are down 13.5p at 72.5p. PM: Well it's not too far below the float – investors shouldn't be too disappointed. It's not one for Sampos and Thain. NH: Well you say that, but it depends when you became an investor. The thing floated at 83p. Within three months it had plunged to below 50p. There's been a strong recovery since December – and then this happens. PM: So you need a strong stomach? NH: Yeah, Entelos might be trying to do great things in the virtual medical research, but in the real world it's just making people sick. NH: Want another one that makes investors variously feel euphoric and then sick as a dog? PM: Go on NH: Blavod Extreme Spirits PM: Glorious name. Sell! NH: Well, steady. It said back at the end of November that it a received a bid approach from an unnamed American group. NH: Then it came out with its interims at the end of December, saying at the time that talks were on-going. NH: Right, well it came out with a trading statement on January 11, which was all very up-beat. NH: Said at the time the approach had a number of pre-conditions – an all share offer valuing the company at £12.8m or a fraction under 18p a share. NH: Well today it has simply said it has terminated discussions because it couldn't get due diligence information from the bidder. NH: So the shares have fallen 1.5p to 8.75p. PM: Just looking at this. This is junk – and it is being treated by the market as piece of junk. PM: After the January statement that it was looking at an 18p-a-share bid, the price managed to move from 10p to 13p – that's a 25% discount. More! PM: 27% NH: Well – the clue is in the statement – the company were very open all along. The bid was from a US company classed as a OTC: BB PM: Oh, goodness, that's AIM Squared NH: I know NH: For those of you who don't know what OTC: BB means – it stands for over the counter bulletin board PM: Yep – the US kerb market – more dangerous than ANYTHING open to investors on this side of the pond. NH: I'm sure this unnamed bidder is completely honest and was making a genuine approach PM: But the fact is OTC:BB stocks are boiler room territory. They are the orginal penny dreadfuls. PM: Of course the bid was never going to work. PM: OK! that's it for today PM: Thanks for joining us. PM: We will be back on Markets Live tomorrow at 11am NH: see you tomorrow
10/9/2006
15:12
mellious: What does anybody expect to happen tommorrow and for the week with the PXC share price considering the following: - - Interim Results. - Bargain Bulldog purchase, and all that can will it, i.e. C & W loops, and the use of pure cash! - Almost complete Toucan acquirement for £24m with the use of current assets (cash/stock), and the ability to offer triple play that would be powerful with the use of economies of scale. - More than 1m customers, more brands and power in various markets (business, consumer etc). - Growth of WIMAX power, i.e. Sky and Intel's advancing. - Constant takeover possibiltiies due to the rareless of a WIMAX license. - Various BUY signals through many investment magazines, newspapers and websites! - The 2-1 late win for Fulham, and the bad injury thus pressing the Pipex logo!! - The hoff's continous press from his new single to come up, the appereance on sharon osbourne's 5pm show and many more hoff related news articles. - And many more news links to Pipex!!! Mel
Pipex share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20161209 21:19:00